Homepage

Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries

Screening Compounds Building blocks

Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls

Company News & Media Contact us For suppliers Trends in discovery compounds

Homepage > Company > Media > Company news > 2016 > ChemDiv and Abbott expand collaboration to develop branded generic pharmaceuticals for high growth emerging markets

ChemDiv and Abbott expand collaboration to develop branded generic pharmaceuticals for high growth emerging markets

Read also

ChemDiv Continues R&D Services Support for Clywedog Therapeutics

ChemDiv Continues R&D Services Support for Clywedog Therapeutics

San Diego, CA — September 30, 2025 — ChemDiv, a global provider of integrated drug discovery solutions, today announced that it will continue providing chemistry,

ChemDiv Partnership with Mondego Bio

ChemDiv Partnership with Mondego Bio

ChemDiv Extends Discovery and Early Development Partnership with Mondego Bio on Best-in-Class PTPN2 Immuno-Oncology Program

Gossamer Bio

Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

Amgen opens new drug substance

Amgen opens new drug substance

Amgen opens new drug substance facility in North Carolina, US